160 related articles for article (PubMed ID: 25576089)
1. A pivotal moment in Alzheimer's disease and dementia: how global unity of purpose and action can beat the disease by 2025.
Vradenburg G
Expert Rev Neurother; 2015 Jan; 15(1):73-82. PubMed ID: 25576089
[TBL] [Abstract][Full Text] [Related]
2. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Thal LJ; Carta A; Doody R; Leber P; Mohs R; Schneider L; Shimohama S; Silber C
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():46-9. PubMed ID: 9305516
[No Abstract] [Full Text] [Related]
3. International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding.
Liggins C; Snyder HM; Silverberg N; Petanceska S; Refolo LM; Ryan L; Carrillo MC
Alzheimers Dement; 2014 May; 10(3):405-8. PubMed ID: 24780512
[TBL] [Abstract][Full Text] [Related]
4. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Winblad B; Hill S; Beermann B; Post SG; Wimo A
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
[No Abstract] [Full Text] [Related]
5. Leveraging global resources to end the Alzheimer's pandemic.
Carrillo MC
Alzheimers Dement; 2013 Jul; 9(4):363-5. PubMed ID: 23809362
[No Abstract] [Full Text] [Related]
6. Alzheimer's disease research in the context of the national plan to address Alzheimer's disease.
Snyder HM; Hendrix J; Bain LJ; Carrillo MC
Mol Aspects Med; 2015; 43-44():16-24. PubMed ID: 26096321
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Homma A; Brodaty H; Bruno G; Cummings JL; Gilman S; Gracon S; McKeith IG
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():54-5. PubMed ID: 9305518
[No Abstract] [Full Text] [Related]
8. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
[No Abstract] [Full Text] [Related]
9. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
[No Abstract] [Full Text] [Related]
10. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
[No Abstract] [Full Text] [Related]
11. The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
Whitehouse PJ
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():2-5. PubMed ID: 9305506
[No Abstract] [Full Text] [Related]
12. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive strategy for dementia from primary prevention to end-stage management.
Arai H
Psychogeriatrics; 2011 Sep; 11(3):131-4. PubMed ID: 21951952
[No Abstract] [Full Text] [Related]
14. [Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort].
Ramaroson H; Helmer C; Barberger-Gateau P; Letenneur L; Dartigues JF;
Rev Neurol (Paris); 2003 Apr; 159(4):405-11. PubMed ID: 12773869
[TBL] [Abstract][Full Text] [Related]
15. Assessing health economic outcome in Alzheimer's disease clinical trials.
Jonsson L
J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
[TBL] [Abstract][Full Text] [Related]
16. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
[No Abstract] [Full Text] [Related]
17. Alzheimer's disease research and development: a call for a new research roadmap.
Feldman HH; Haas M; Gandy S; Schoepp DD; Cross AJ; Mayeux R; Sperling RA; Fillit H; van de Hoef DL; Dougal S; Nye JS;
Ann N Y Acad Sci; 2014 Apr; 1313():1-16. PubMed ID: 24754377
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
19. New set of Alzheimer's trials focus on prevention.
Corbyn Z
Lancet; 2013 Feb; 381(9867):614-5. PubMed ID: 23444487
[No Abstract] [Full Text] [Related]
20. Prevention of Alzheimer's disease: a global challenge for next generation neuroscientists.
Rodríguez-Gómez O; Palacio-Lacambra ME; Palasí A; Ruiz-Laza A; Boada-Rovira M
J Alzheimers Dis; 2014; 42 Suppl 4():S515-23. PubMed ID: 25351111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
